Compliance
Homeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted that over the past 12 months, the HPCUS held almost 40 meetings; the pandemic circumstances forced all to be held readm more…
Read MoreFDA Eyes Improvements to Nonprescription Drug Labeling
What impact will that have on your products? The top line: Two years after issuing draft guidance on “innovative” nonprescription drug labeling, the FDA is again thinking about potential improvements to the Drug Facts Label. First, let’s explain a bit about the regulation of labels for nonprescription drugs. Nonprescription, or readm more…
Read MoreAAHP Disclaimer: Continuing to Deliver Value After Five Years
The AAHP disclaimer, “Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated,” benefits from the best support among disclaimers I have seen – Use It! Mark Land, AAHP President In preparing to write this article, I reviewed a report I wrote about a year before readm more…
Read MoreAAHP Disclaimer Helps Win Two Lawsuits
Advancing Goal of Informing Consumers & Protecting Sellers By Alvin J. Lorman, Association Counsel If you’ve wondered whether the American Association of Homeopathic Pharmacists’ (AAHP) recommended consumer label and advertising disclaimer deserves the valuable space it occupies, we now have a judicial answer. AAHP’s disclaimer: “Claims based on readm more…
Read MoreYour Reputation Precedes You
By Mark Land, AAHP President | Brian Westerlind, Editor of the Network News, writes in his article on warning letters – “Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.”
Read More4 Simple Ways to Keep Your Homeopathic Manufacturing Process Safe and Effective
Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.
We’ve reviewed recent Warning Letters from the U.S. FDA—which highlight some of the most common missteps and shortcomings—and have put together these four basic ground rules that can help any homeopathic manufacturer or marketer strive toward excellence.
Read MorePoison Control Center Statistics on Homeopathy
What’s Your Company’s Safety Statistics? When FDA announced its public hearing on homeopathy, the agency cited 10,311 reported poison exposure cases related to “homeopathic agents” in the 2012 American Association of Poison Control Centers Annual Report. This article will introduce a new program by the National Capital Poison Center readm more…
Read MoreWhat is the HPUS and Who Creates It?
By Eric L. Foxman, R.Ph., senior scientist, HPCUS Homeopathic pharmacopoeias have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication for over 120 years — since 1897. It became officially recognized under the U.S. Food Drug and Cosmetic Act in readm more…
Read MoreFDA Warning Letter Lessons?
By Eric L. Foxman, R.PH., AAHP Secretary Of all the Warning Letters issued by the FDA, very few go to homeopathic manufacturers or marketers. That’s good. On the other hand, the few that are addressed to members of our industry reveal a wide divide between what is required by 21 readm more…
Read MoreHomeopathic Process Validation for Beginners
Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it through process validation. Each manufacturer must ask themselves: Do I have scientific evidence that my (manufacturing) process is capable of reliably delivering quality product? readm more…
Read More